⌘K

Home/Filings/4/0001442772-09-000001

4//SEC Filing

Brady Patrick Robert 4

Accession 0001442772-09-000001

CIK 0000949858other

View on SEC.gov Company Profile

Filed

Dec 23, 7:00 PM ET

Accepted

Dec 24, 8:10 PM ET

Size

14.9 KB

Accession

0001442772-09-000001

Insider Transaction Report

Form 4

Period: 2009-12-22

ONCOGENEX PHARMACEUTICALS, INC.ogxi

Brady Patrick Robert

Director

Transactions

Exercise/Conversion
Common Stock
2009-12-22$2.69/sh+5,359$14,416→ 5,359 total(indirect: See note)
Exercise/Conversion
Common Stock
2009-12-22$2.69/sh+11,641$31,314→ 17,000 total(indirect: See note)
Exercise/Conversion
Stock Option (Right to Buy0
2009-12-22−5,359→ 0 total
Exercise: $2.69From: 2009-12-22Exp: 2010-03-23→ Common Stock (5,359 underlying)
Exercise/Conversion
Common Stock
2009-12-22$7.25/sh+4,130$29,943→ 21,130 total(indirect: See note)
Exercise/Conversion
Stock Option (Right to Buy0
2009-12-22−4,130→ 0 total
Exercise: $7.25From: 2009-12-22Exp: 2010-03-23→ Common Stock (4,130 underlying)
Exercise/Conversion
Stock Option (Right to Buy0
2009-12-22−11,641→ 0 total
Exercise: $2.69From: 2009-12-22Exp: 2009-12-23→ Common Stock (11,641 underlying)

Footnotes (1)

[F1]These shares were issued to Working Opportunity Fund (EVCC) Ltd. upon the exercise of a stock option held by Mr. Brady. Mr. Brady is a Vice-President of Growthworks Capital Ltd., an affiliate of Working Opportunity Fund (EVCC) Ltd.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ONCOGENEX PHARMACEUTICALS, INC.

CIK 0000949858

Entity typeother

Related Parties

1

filerCIK 0001442772

Filing Metadata

Form type: 4
Filed: Dec 23, 7:00 PM ET
Accepted: Dec 24, 8:10 PM ET
Size: 14.9 KB

View on SEC.gov